InterCure Announces Expansion of its Strategic Partnership with Cookies to Germany Page 1

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”), the leading vertically integrated medical cannabis company outside of North America, announces a new strategic agreement with Cookies, the globally recognized cannabis brand, to cultivate, manufacture, import and distribute Cookies branded products, produced from its cultivation and manufacturing facilities, initially in 8 licensed branded dispensaries across Germany, through Cookies Corners. This agreement marks an expansion of InterCure and Cookies’ partnership footprint in Europe, which now includes the United Kingdom, Austria and Germany, in addition to strategic collaborations in Israel.

Under the terms of the new agreement, InterCure will grow and manufacture Cookies-licensed genetics and products in its global supply chain facilities. InterCure’s EU-GMP manufacturing sites will import, register and manufacture Cookies-branded products, including future lines of next-generation offerings such as live resin and live rosin products and vapes. These products will be distributed through InterCure’s Cookies Corner-licensed dispensaries and online platforms, distinguished by the official Cookies shopping experience.